Behaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion model

References

• Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M. 2011. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther 9:1035–1052.
   PubMed Web of Science ®Google Scholar
• Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA, et al. 2008. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol 5:14.
   PubMed Web of Science ®Google Scholar
• Bouwmeester H, Dekkers S, Noordam MY, Hagens WI, Bulder AS, de Heer C, et al. 2009. Review of health safety aspects of nanotechnologies in food production. Regul Toxicol Pharm 53:52–62.
   PubMed Web of Science ®Google Scholar
• Brandon EF, Oomen AG, Rompelberg CJ, Versantvoort CH, van Engelen JG, Sips AJ. 2006. Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment. Regul Toxicol Pharmacol 44:161–171.
   PubMed Web of Science ®Google Scholar
• Cedervall T, Lynch I, Foy M, Berggard T, Donnelly SC, Cagney G, et al. 2007. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl 46:5754–5756.
   PubMed Web of Science ®Google Scholar
• Chaudhry Q, Scotter M, Blackburn J, Ross B, Boxall A, Castle L, et al. 2008. Applications and implications of nanotechnologies for the food sector. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25:241–258.
   PubMed Web of Science ®Google Scholar
• Chen X, Schluesener HJ. 2008. Nanosilver: a nanoproduct in medical application. Toxicol Lett 176:1–12.
   PubMed Web of Science ®Google Scholar
• Cheng D, Xia H, Chan HS. 2004. Facile fabrication of AgCl@polypyrrole-chitosan core-shell nanoparticles and polymeric hollow nanospheres. Langmuir 20:9909–9912.
   PubMed Web of Science ®Google Scholar
• Choi O, Clevenger TE, Deng B, Surampalli RY, Ross L Jr, Hu Z. 2009. Role of sulfide and ligand strength in controlling nanosilver toxicity. Water Res 43:1879–1886.
   PubMed Web of Science ®Google Scholar
• Danscher G, Stoltenberg M. 2006. Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles. Prog Histochem Cytochem 41:57–139.
   PubMed Web of Science ®Google Scholar
• Drake PL, Hazelwood KJ. 2005. Exposure-related health effects of silver and silver compounds: a review. Ann Occup Hyg 49:575–585.
   PubMed Web of Science ®Google Scholar
• EFSA, Committee ES. 2011. Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA J 9:36.
   Google Scholar
• El Badawy AM, Luxton TP, Silva RG, Scheckel KG, Suidan MT, Tolaymat TM. 2010. Impact of environmental conditions (pH, ionic strength, and electrolyte type) on the surface charge and aggregation of silver nanoparticles suspensions. Environ Sci Technol 44:1260–1266.
   PubMed Web of Science ®Google Scholar
• Fabrega J, Fawcett SR, Renshaw JC, Lead JR. 2009. Silver nanoparticle impact on bacterial growth: effect of pH, concentration, and organic matter. Environ Sci Technol 43:7285–7290.
   PubMed Web of Science ®Google Scholar
• Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. 2009. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 190:156–162.
   PubMed Web of Science ®Google Scholar
• Greulich C, Kittler S, Epple M, Muhr G, Koller M. 2009. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg 394:495–502.
   PubMed Web of Science ®Google Scholar
• Huynh KA, Chen KL. 2011. Aggregation kinetics of citrate and polyvinylpyrrolidone coated silver nanoparticles in monovalent and divalent electrolyte solutions. Environ Sci Technol 45:5564–5571.
   PubMed Web of Science ®Google Scholar
• Jonas L, Bloch C, Zimmermann R, Stadie V, Gross GE, Schad SG. 2007. Detection of silver sulfide deposits in the skin of patients with argyria after long-term use of silver-containing drugs. Ultrastruct Pathol 31:379–384.
   PubMed Web of Science ®Google Scholar
• Kittler S, Greulich C, Diendorf J, Koller M, Epple M. 2010. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem Mater 22:4548–4554.
   Web of Science ®Google Scholar
• Laborda F, Jimenez-Lamana J, Bolea E, Castillo JR. 2011. Selective identification, characterization and determination of dissolved silver(I) and silver nanoparticles based on single particle detection by inductively coupled plasma mass spectrometry. J Anal Atom Spectrom 26:1362–1371.
   Web of Science ®Google Scholar
• Levard C, Reinsch BC, Michel FM, Oumahi C, Lowry GV, Brown GE. 2011. Sulfidation processes of PVP-coated silver nanoparticles in aqueous solution: impact on dissolution rate. Environ Sci Technol 45:5260–5266.
   PubMed Web of Science ®Google Scholar
• Li L, Zhu YJ. 2006. High chemical reactivity of silver nanoparticles toward hydrochloric acid. J Colloid Interface Sci 303:415–418.
   PubMed Web of Science ®Google Scholar
• Li X, Lenhart JJ, Walker HW. 2010. Dissolution-accompanied aggregation kinetics of silver nanoparticles. Langmuir 26:16690–16698.
   PubMed Web of Science ®Google Scholar
• Liu J, Hurt RH. 2010. Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ Sci Technol 44:2169–2175.
   PubMed Web of Science ®Google Scholar
• Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18.
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–14270.
   PubMed Web of Science ®Google Scholar
• Lynch I, Dawson KA. 2008. Protein-nanoparticle interactions. Nano Today 3:40–47.
   Web of Science ®Google Scholar
• Meziani MJ, Sun YP. 2003. Protein-conjugated nanoparticles from rapid expansion of supercritical fluid solution into aqueous solution. J Am Chem Soc 125:8015–8018.
   PubMed Web of Science ®Google Scholar
• Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239–253.
   PubMed Web of Science ®Google Scholar
• Nanoparticle Products Inventory, PEN. http://www.nanotechproject.org/.
   Google Scholar
• Nath N, Chilkoti A. 2004. Label-free biosensing by surface plasmon resonance of nanoparticles on glass: optimization of nanoparticle size. Anal Chem 76:5370–5378.
   PubMed Web of Science ®Google Scholar
• Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, et al. 2008. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol 42:8959–8964.
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8.
   PubMed Web of Science ®Google Scholar
• Oomen AG, Tolls J, Sips AJAM, Van den Hoop MAGT. 2003. Lead speciation in artificial human digestive fluid. Arch Environ Contam Toxicol 44:107–115.
   PubMed Web of Science ®Google Scholar
• Pace HE, Rogers NJ, Jarolimek C, Coleman VA, Higgins CP, Ranville JF. 2011. Determining transport efficiency for the purpose of counting and sizing nanoparticles via single particle inductively coupled plasma mass spectrometry. Anal Chem 83:9361–9369.
   PubMed Web of Science ®Google Scholar
• Peters R, Kramer E, Oomen AG, Herrera Rivera ZE, Oegema G, Tromp PC, et al. 2012. Presence of nano-sized silica during in vitro digestion of foods containing silica as a food additive. ACS Nano 6(3):2441–2451.
   PubMed Web of Science ®Google Scholar
• Rai M, Yadav A, Gade A. 2009. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76–83.
   PubMed Web of Science ®Google Scholar
• Rogers KR, Bradham K, Tolaymat T, Thomas DJ, Hartmann T, Ma L, et al. 2012. Alterations in physical state of silver nanoparticles exposed to synthetic human stomach fluid. Sci Total Environ 420:334–339.
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, et al. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452–461.
   PubMed Web of Science ®Google Scholar
• Tien DC, Tseng KH, Liao CY, Tsung TT. 2008. Colloidal silver fabrication using the spark discharge system and its antimicrobial effect on Staphylococcus aureus. Med Eng Phys 30:948–952.
   PubMed Web of Science ®Google Scholar
• Versantvoort CH, Oomen AG, Van de Kamp E, Rompelberg CJ, Sips AJ. 2005. Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food. Food Chem Toxicol 43:31–40.
   PubMed Web of Science ®Google Scholar
• Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. 2010. What the cell "Sees" in bionanoscience. J Am Chem Soc 132:5761–5768.
   PubMed Web of Science ®Google Scholar
• Zelyanskii AV, Zhukova LV, Kitaev GA. 2001. Solubility of AgCl and AgBr in HCl and HBr. Inorg Mater 37:523–526.
   Web of Science ®Google Scholar